Production and characterization of a cross-reactive monoclonal antibody to lipopolysaccharide

Hybridoma

Volumn 28, Issue 2, 2009, Pages 93-99

  Jiang, Xiao Tao ^a   Liu, Bei Yi ^a   Zhu, Ping ^a   Fu, Ning ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CROSS REACTING ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY SMU 3A8; SYNTHETIC PEPTIDE; THYMUS INDEPENDENT ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY ENGINEERING; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL CELL; BINDING AFFINITY; CONTROLLED STUDY; CROSS REACTION; DOT ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRAM NEGATIVE BACTERIUM; HYBRIDOMA; IMMUNIZATION; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; WESTERN BLOTTING; WHOLE CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; BIOTECHNOLOGY; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; LIPOPOLYSACCHARIDES; MICE;

MURINAE; NEGIBACTERIA;

EID: 65349142482     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2008.0075     Document Type: Article

References (32)

1. Chorny A, Anderson P, Gonzalez-Rey E, and Delgado M: Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria. J Immunol 2008(12);180:8369-8377.
2. Russell JA: Management of sepsis. N Engl J Med 2006; 355(16):1699-713.
3. Martin GS, Mannino DM, Eaton S, and Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348(16):1546-1554.
4. Di Padova FE, Brade H, Barclay GR, Poxton IR, Liehl E, Schuetze E, Kocher HP, Ramsay G, Schreier MH, McClelland DB, and Rietschel ET: A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmo-nella lipopolysaccharides. Infect Immun 1993;61(9):3863-3872.
5. Ziegler EJ, Fisher CJ Jr, Sprung CL, Straube RC, Sadoff JC, Foulke GE, Wortel CH, Fink MP, Dellinger RP, and Teng NN: Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. New Engl J Med 1991;324(7):429-436.
6. Greenman RL, Schein RM, Martin MA, Wenzel RP, Mac Intyre NR, Emmanuel G, Chmel H, Kohler RB, McCarthy M, and Plouffe J: A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of Gram-negative sepsis. J Am Med Assoc 1991;266(8):1097-1102.
7. Wortel CH, von der Mohlen MA, van Deventer SJ, Sprung CL, Jastremski M, Lubbers MJ, Smith CR, Allen IE, and ten Cate JW: Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels. J Infect Dis 1992; 166(6):1367-1374.
8. Hitchcock PJ, Leive L, Makelä PH, Rietschel ET, Strittmatter W, and Morrison DC: Lipopolysaccharide nomenclature-past, present, and future. J Bacteriol 1986;166(3):699-705.
9. Koch G, Lok BD, and Benner R: Antibody formation in mouse bone marrow during secondary type responses to various thymus-independent antigens. Immunobiology 1982;163(5):484-496.
10. Clement M-J, Fortune; A, Phalipon A, Marcel-Peyre V, Simenel C, Imberty A, Delepierre M, and Mulard LA: Toward a better understanding of the basis of the molecular mimicry of polysaccharide antigens by peptides. J Biol Chem 2006;281(4):2317-2332.
11. Lanzillottia R, and Coetzera TL: Phage display: a useful tool for malaria research? Trends Parasitol 2008;24(1):18-23.
12. Petty NK, Evans TJ, Fineran PC, and Salmond GP: Bio-technological exploitation of bacteriophage research (Related Articles). Trends Biotechnol 2007;25(1):7-15.
13. Wang LF, and Yu M: Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics. Curr Drug Targets 2004;5(1):1-15.
14. Grothaus MC, Srivastava N, Smithson SL, Kieber-Emmons T, Williams DB, Carlone GM, and Westerink MA: Selection of an immunogenic peptide mimic of the capsular polysaccharide of Neisseria meningitidis serogroup A using a peptide display library. Vaccine 2000;18(13):1253-1263.
15. Park I, Choi IH, Kim SJ, and Shin JS: Peptide mimotopes of Neisseria meningitidis group B capsular polysaccharide. Yonsei Med J 2004;45(4):755-758.
16. Prinz DM, Smithson SL, and Westerink MA: Two different methods result in the selection of peptides that induce a protective antibody response to Neisseria meningitidis ser-ogroup C. J Immunol Methods 2004;285(1):1-14.
17. Luo HB, Zheng SG, Zhu P, and Fu N: Study on mimotopes of E. coli lipopolysaccharide 2630. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2004;20(6):682-685.
18. Cuello AC, and Cote A: Preparation and Application of Conventional and Non-conventional Monoclonal Antibodies. Wiley & Sons, New York, 1993.
19. Gidney MA, Plested JS, Lacelle S, Coull PA, Wright JC, Makepeace K, Brisson JR, Cox AD, Moxon ER, and Richards JC: Development, characterization, and functional activity of a panel of specific monoclonal antibodies to inner core lipopolysaccharide epitopes in Neisseria meningitidis. Infect Immun 2004;72(1):559-569.
20. Beatty JD, Beatty BG, and Vlahos WG: Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J Immunol Methods 1987;100(1-2):173-179.
21. Di Padova FE, Brade H, Barclay GR, Poxton IR, Liehl E, Schuetze E, Kocher HP, Ramsay G, Schreier MH, and McClelland DB: A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysac-charides. Infect Immun 1993;61(9):3863-3872.
22. Singh SP, Miller S, Williams YU, Klebba PE, Macchia P, and Marshall N: Recognition specificity of monoclonal antibodies which protect mice against Salmonella typhimurium infection. Res Microbiol 1999;150(6):385-394.
23. Mertens P, Walgraffe D, Laurent T, Deschrevel N, Letesson JJ, and De Bolle X: Selection of phage-displayed peptides recognised by monoclonal antibodies directed against the lipopolysaccharide of Brucella. Int Rev Immunol 2001;20(2): 181-199.
24. Muller-Loennies S, Brade L, MacKenzie CR, Di Padova FE, and Brade H: Identification of a cross-reactive epitope widely present in lipopolysaccharide from enterobacteria and recognized by the cross-protective monoclonal antibody WN1 222-225. J Biol Chem
25. Pantophlet R, Severin JA, Nemec A, Brade L, Dijkshoorn L, and Brade H: Identification of Acinetobacter isolates from species belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with monoclonal antibodies specific for O antigens of their lipopolysaccharides. Clin Diagn Lab Immunol 2002;9(1):60-65.
26. Charalambous BM, and Feavers IM: Peptide mimics elicit antibody responses against the outer-membrane lipooligo-saccharide of group B neisseria meningitidis. FEMS Micro-biol Lett 2000;191(1):45-50.
27. Lauvrak V, Berntzen G, Heggelund U, Herstad TK, Sandin RH, Dalseg R, Rosenqvist E, Sandlie I, and Michaelsen TE: Selection and characterization of cyclic peptides that bind to a monoclonal antibody against meningococcal L3,7,9 lipo-polysaccharides. Scand J Immunol 2004;59(4):373-384.
28. Manosalva H, De Ioannes AE, and Becker MI: Development of monoclonal antibodies bearing the internal image of the Gizzerosine epitope and application in a competitive ELISA for fish meal. Hybrid Hybridomics 2004;23(1):45-54.
29. De Ioannes P, Moltedo B, Oliva H, Pacheco R, Faunes F, De Ioannes AE, and Becker MI: Hemocyanin of the molluscan Concholepas concholepas exhibits an unusual heterodeca-meric array of subunits. J Biol Chem 2004;279(25):26134- 26142.
30. Oliva H, Moltedo B, De Ioannes P, Faunes F, De Ioannes AE, and Becker MI: Monoclonal antibodies to molluskan hemo-cyanin from Concholepas concholepas demonstrate common and specific epitopes among subunits. Hybrid Hybridomics 2002;21(5):365-374.
31. Rietschel ET, Brade H, Lindner B, and Zahringer U: Molecular biochemistry of lipopolysaccharides. In: Morrison DC, and Ryan JL (Eds.), Bacterial Endotoxic Lipopolysaccharides, vol. 1: Molecular Biochemistry and Cellular Biology. CRC Press,Boca Raton, 1992, pp. 3-42.
32. Rietschel ET, and Westphal O: Endotoxin: historical perspectives. In: Brade H, Opal SM, Vogel SN, and Morrison DC (Eds.), Endotoxin in Health and Disease. Marcel Dekker, New York, 1999, pp. 1-30.